Develops, produces and markets pharmaceutical drugs
Actelion Ltd. is a biopharmaceutical company, which engages in the development and commercialization of drugs.
The company discovers, develops and commercializes innovative low molecular weight drugs for high unmet medical needs.
Its products are used for human therapeutics for life threatening diseases such as cardiovascular, cardiopulmonary, immunological, metabolic, and nervous system disorders.
The company was founded by by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Mueller, and Thomas Widmann on December 17, 1997 and is headquartered in Allschwil, Switzerland.